期刊文献+

糖尿病和癌症共识报告——美国糖尿病协会、美国癌症学会公布 被引量:5

Diabetes and Cancer: A Consensus Report
原文传递
导出
摘要 流行病学证据显示:癌症发生率和糖尿病、某些糖尿病风险因子以及糖尿病治疗有关。由美国糖尿病协会(ADA)和美国癌症学会(ACS)汇集的专家共识,回顾了科学研究现状。包括:(1)糖尿病和癌症发生及预后的关系:(2)糖尿病和癌症共同的危险因子。(3)在糖尿病和癌症风险之间可能的生物学联系。(4)糖尿病的治疗是否影响癌症发生及预后。糖尿病和癌症都是常见病,严重影响着人类的健康。流行病学证据显示:糖尿病患者有发生多种癌症的较高风险;2型糖尿病(T2DM)和癌症有许多共同的危险因子。但目前T2DM和癌症之间的生物学联系尚未完全明了。而且,观察性研究的证据还显示:某些治疗高血糖的药物,增加或减少癌症发生的风险。鉴于此,ADA和ACS在2009年12月的研讨会上达成以下共识。 Epidemiologic evidence suggests that cancer incidence is associated with diabetes as well as certain diabetes risk factors and treatments. This consensus statement of experts assembled jointly by the American Diabetes Association and the American Cancer Society reviews the state of science concerning: ( 1 ) the association between diabetes and cancer incidence or prognosis. (2) risk factors common to both diabetes and cancer. (3) possible biologic links between diabetes and cancer risk. and (4) whether diabetes treatments influence the risk of cancer or cancer prognosis. Diabetes and cancer are common diseases that have a tremendous impact on health worldwide. Epidemiologic evidence suggests that people with diabetes are at a significantly higher risk of many forms of cancer. Type 2 diabetes and cancer share many risk factors, but to our knowledge,potential biologic links between two diseases are incompletely underslood. Moreover,evidence from obsmwational studies suggests that some medications used to treat hyperglycemia are associated with either an increased or reduced risk of cancer. Against this backdrop,the American Diabetes Association and the American Cancer Society convened a consensus development conference in December 2009.
出处 《国际内分泌代谢杂志》 2010年第5期353-358,共6页 International Journal of Endocrinology and Metabolism
关键词 糖尿病 癌症 美国糖尿病协会 美国癌症学会 Diabetes mellitus Cancer American Diabeles Association American Cancer Society
  • 相关文献

同被引文献32

  • 1胡水清,汤哲,张玫.糖尿病与结直肠癌患病危险关系的调查分析[J].世界华人消化杂志,2007,15(1):88-91. 被引量:27
  • 2匡天涛,靳大勇,楼文晖,王单松,许雪峰,倪晓凌,吴文川.胰腺癌与糖尿病关系的临床流行病学研究[J].中华消化杂志,2007,27(1):12-14. 被引量:23
  • 3陆再英,钟南山.内科学[M].第7版.北京:人民卫生出版社.2008:251.
  • 4Liao S, Li J, Wei W, et al. Association between Diabetes Mellitus and Breast Cancer Risk: a Meta-analysis of the Literature. Asian Pac J Cancer Prey, 2011, 12: 1061-1065.
  • 5Lai A, Sarcevic B, Prall OW, et al. Insulin/insulin-like growth factor-I and estrogen cooperate to stimulate cyclin E-Cdk2 activation and cell Cycle progression in MCF-7 breast cancer cells through differential regulation of cyclin E and p21 ( WAF1/Cipl ). J Biol Chem, 2001, 276: 25823-25833.
  • 6Mohanraj L, Y Oh. Targeting IGF-I, IGFBPs and IGF-I receptor system in cancer: the current and future in breast cancer therapy. Recent Pat Anticancer Drug Discov, 2011,6: 166-177.
  • 7Frankenberry KA, Skinner H, Somasundar P, et al. Leptin receptor expression and cell signaling in breast cancer. International J Oncol, 2006, 28 : 985-993.
  • 8Larsson SC, Mantzoros CS, Wolk A. Diabetes mellitus and risk of breast cancer: a meta-analysis. Int J Cancer, 2007, 121: 856- 862.
  • 9Koensgen D, Freitag C, Klaman I, et al. Expression and Localization of E-Cadherin in epithelial ovarian cancer. Anticancer Res, 2010, 30: 2525-2530.
  • 10Gottardi C J, Wong E, Gumbiner BM. E-eadherin suppresses cellular transformation by inhibiting [ beta ]-catenin signaling in an adhesion-independent manner. J Cell Biol, 2001, 153: 1049- 1060.

引证文献5

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部